May 2018-Global Life Science Business Partnering - News & Updates

Highlights for May 2018

  1. Aurobindo Pharma launches $1.6B bid to buy Novartis generics unit which includes an array of dermatology brands, production facilities and associated infrastructure, mostly in the US.
  2. Elite Pharmaceuticals Announces Strategic Marketing Alliance with Glenmark to market two Elite generic products in US.
  3. Stempeutics has signed an out-licensing deal with Cipla for Stempeucel product targeting critical limb ischemia- peripheral arterial disease (CLI-PAD).
  4. Strides Shasun to merge business with Apotex To Create Australia’s No. 1 Generics Drugmaker by volume and revenue.
  5. Cipla partners US based MannKind Corporation for marketing, distribution of inhaled insulin Afrezza in India.
  6. Aurobindo Pharma has re-engaged with Mallinckrodt to acquire its specialty generics portfolio.
  7. Cara Therapeutics signs $540M deal with Fresenius and Vifor Pharma to commercialize Korsuva injection.
  8. Denali acquires F-star's blood-brain barrier bispecific antibody tech in deal worth up to $471M.
  9. Zymeworks and Daiichi Sankyo expand Immuno-Oncology collaboration focused on Bispecific Antibodies with an upfront technology access fee of $18M and up to $466.7M in milestone payments.
  10. Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Indo-Pacific Region Including Japan with a $25M upfront payment.
  11. J&J to acquire BeneVir Biopharm to Advance Immunotherapy Regimens for $140M upfront.
  12. Luye Pharma Group announced acquisition of AstraZeneca's core CNS products - Seroquel and Seroquel XR with an initial payment of $260M.
  13. Karyopharm and Antengene sign exclusive license agreement for $12M upfront; Total Deal Valued at up to $162M with Karyopharm Eligible to receive up to $150M in future milestones, plus royalties.

Updates at Aagami: 

  1. New Client Win: Aagami to support cross border partnering of a Next Generation PEGylation technology and associated assets of a California company.
  2. Aagami receives another assignment from an Existing client focused on Women’s Health
  3. Aagami CEO along with a client, completed a fruitful strategic business trip to New York and New Jersey.
  4. Aagami to attend BIO International Convention in Boston, MA 04-07 June, 2018 with more than 40+ one-to-one partnering meetings already scheduled.
  5. Aagami to represent multiple clients at the BIO International Convention, 2018.
×
Twitter